相关实验视频
Updated: Sep 19, 2025

09:36
Changes in Mammary Gland Morphology and Breast Cancer Risk in Rats
Published on: October 16, 2010
29.8K
超菌血症和癌症风险:瑞典基于人口的队列研究
Endocrine connections
|June 6, 2025
概括
接受多巴胺激动剂 (DA) 治疗的患有高血糖性血症 (HPL) 的患者没有增加患整体癌症或乳腺癌的风险. 这项全国性的研究证实了HPL患者癌症风险的安全性.
科学领域:
- 内分泌学和瘤学的内分泌学和瘤学.
- 生殖内分泌学 生殖内分泌学
- 癌症流行病学 癌症流行病学
背景情况:
- 众所周知,益生菌 (PRL) 促进细胞增殖,在各种癌症中观察到PRL受体表达升高.
- 尽管PRL在细胞生长中的作用有限,但有限的研究已经探讨了患有高血性血 (HPL) 个体的癌症风险.
研究的目的:
- 调查高血性乳腺炎 (HPL) 与癌症风险之间的关联,特别关注乳腺癌.
- 分析在全国范围内诊断出HPL并接受多巴胺激动剂 (DA) 治疗的患者队列中的癌症发病率.
主要方法:
- 瑞典一项基于人口的队列研究在2006年至2019年期间确定了3,837名HPL患者接受DA治疗.
- 38,370个匹配的对照人群根据年龄,性别,日历年和居住县进行了选择.
- 用考克斯回归分析了癌症的结果,调整了相关的共变量,以计算调整的危险比率 (aHR).
主要成果:
- 在平均6.1年的随访期间,HPL组 (4.6%) 和对照组 (4.4%) (aHR1.05) 之间没有发现癌症总发病率的显著差异.
- 乳腺癌发病率在两组中都相似 (HPL患者的0.7%,对照组的0.7%),aHR为1.02.
- 在患有HPL的患者中,没有观察到任何其他特定部位癌症的风险增加.
结论:
- 这项全国性的研究表明,用多巴胺激动剂 (DA) 治疗的高血糖性血症 (HPL) 与整体癌症风险的增加无关.
- 这些发现表明,HPL患者的乳腺癌或其他特定部位恶性瘤的风险没有增加.
- 这项研究为HPL管理的个人提供了关于长期癌症风险的保证.
更多相关视频
12:57X-Ray Visualization of Intraductal Ethanol-Based Ablative Treatment for Prevention of Breast Cancer in Rat Models
Published on: December 9, 2022
2.4K
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
1.7K
相关概念视频
Psychoneuroimmunology: Diabetes and Cancer
68
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
68
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Cancer Prevention
6.3K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.3K
Cancer Survival Analysis
458
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
458
Hazard Ratio
263
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
263
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
184
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
184